Form 4: ENDRA CEO Alexander Tokman Boosts Stake

ENDRA Life Sciences CEO Alexander Tokman acquired 26,921 restricted stock units, increasing his beneficial ownership to 101,926 shares.

Summary

• Alexander Y. Tokman, Chief Executive Officer and Director of ENDRA Life Sciences Inc. (NDRA), acquired 26,921 shares of common stock.
• The acquisition occurred on March 2, 2026, and represents Restricted Stock Units (RSUs) that convert to common stock on a one-for-one basis.
• These RSUs were acquired at a price of $0, indicating they are part of a compensation package.
• Following this transaction, Mr. Tokman's total beneficial ownership in ENDRA Life Sciences Inc. stands at 101,926 shares of common stock.
• The acquired RSUs are scheduled to vest in full on June 11, 2026.

Sentiment

Score: 7

Explanation: StockSavvy.ai views this as a moderately positive development. While an RSU grant is a form of compensation rather than an open-market purchase, it increases the CEO's direct equity stake, aligning his interests with long-term shareholder value.

Positives

• The acquisition of additional shares by the CEO, even through RSU grants, demonstrates continued alignment of management's interests with those of shareholders.
• An increase in insider ownership can be viewed as a positive signal regarding management's confidence in the company's future prospects.

Industry Context

StockSavvy.ai notes that insider transactions, particularly acquisitions, are often closely watched by investors as they can signal management's belief in the company's future performance. While RSU grants are a common form of executive compensation and not an open-market purchase, they still increase an executive's direct stake and align their financial incentives with shareholder value creation.

Stakeholder Impact

• Shareholders may view the increased insider ownership as a positive indicator of management's commitment and confidence in the company's future.
• Employees may see this as a standard part of executive compensation, potentially reinforcing stability in leadership.

Next Steps

• The 26,921 Restricted Stock Units are scheduled to vest in full on June 11, 2026.

Key Dates

Recommendation

While the increase in insider ownership through RSU grants is a positive signal of management alignment, a single Form 4 filing, especially for compensation-related shares, typically does not provide sufficient information to warrant a change in a seasoned investor's fundamental recommendation. It reinforces a 'hold' stance by indicating continued executive commitment.

Keywords

ENDRA Life Sciences, NDRA, Alexander Y. Tokman, CEO, Insider Transaction, Form 4, Restricted Stock Units, RSU, Equity Compensation, Beneficial Ownership